CYP4F22 encodes fatty acid ω-hydroxylase essential for acylceramide synthesis and therefore for CLE formation [37], and mutations in this gene have been identified in LI, CIE, and SICI patients [38,39]. This evidence concerns the gene CYP4F22 and congenital non-bullous ichthyosiform erythroderma.